Ganga Pharmaceuticals Ltd Peer Comparison
GANGAPHARM · Healthcare · Current price ₹12.5
Peers tracked
16
Ganga Pharmaceuticals Ltd P/E
73.5x
Sector
Healthcare
Ganga Pharmaceuticals Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Divis Laboratories Ltd | ₹9,322 | 69.1x | 2,47,576 |
| Zydus Lifesciences Ltd | ₹1,119.1 | 22.0x | 1,11,671 |
| Cipla Ltd | ₹1,366 | 30.3x | 1,10,273 |
| Laurus Labs Ltd | ₹1,969 | 92.8x | 1,06,460 |
| Dr Reddys Laboratories Ltd | ₹1,165.5 | 26.8x | 96,902 |
| Aurobindo Pharma Ltd | ₹1,679.8 | 25.9x | 96,402 |
| Lupin Ltd | ₹2,095 | 20.6x | 95,843 |
| Mankind Pharma Ltd | ₹2,280 | 53.7x | 94,050 |
| Glenmark Pharmaceuticals Ltd | ₹2,419.2 | 45.5x | 68,211 |
| Biocon Ltd | ₹390.65 | 175.9x | 63,713 |
| Alkem Laboratories Ltd | ₹5,087.5 | 28.6x | 60,853 |
| Abbott India Ltd | ₹25,550 | 35.2x | 54,369 |
Ganga Pharmaceuticals Ltd versus its peers
Ganga Pharmaceuticals Ltd operates in the Healthcare space alongside 16 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 73.5x may be cheap in one industry and expensive in another.
More on Ganga Pharmaceuticals Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.